BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34865353)

  • 1. [Study on the state of macrophage infiltration in the progression of non-alcoholic fatty liver disease induced by high-fat diet in mice].
    Zhong L; Xu KS; Deng L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1042-1047. PubMed ID: 34865353
    [No Abstract]   [Full Text] [Related]  

  • 2. The Influence of Emodin Succinyl Ethyl Ester on Non-alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice.
    Wang Y; Li L; Chen L; Xia J; Wang T; Han L; Cao L; Wang Z; Xiao W; Jiang S
    Biol Pharm Bull; 2024 May; 47(5):978-987. PubMed ID: 38631865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.
    Ding J; Xu M; Du W; Fang ZQ; Xu H; Liu JJ; Song P; Xu C; Li ZW; Yue ZS; Ling YW; Duan JL; Tao KS; He F; Wang L
    Int J Biol Sci; 2023; 19(6):1941-1954. PubMed ID: 37063432
    [No Abstract]   [Full Text] [Related]  

  • 4. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    de Oliveira S; Houseright RA; Graves AL; Golenberg N; Korte BG; Miskolci V; Huttenlocher A
    J Hepatol; 2019 Apr; 70(4):710-721. PubMed ID: 30572006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.
    Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X
    Front Immunol; 2023; 14():1113883. PubMed ID: 36776889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.
    Du Y; Paglicawan L; Soomro S; Abunofal O; Baig S; Vanarsa K; Hicks J; Mohan C
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33670347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
    Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
    Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease.
    Komatsu G; Nonomura T; Sasaki M; Ishida Y; Arai S; Miyazaki T
    Exp Anim; 2019 May; 68(2):147-158. PubMed ID: 30487357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
    Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
    J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.
    Xu L; Chen Y; Nagashimada M; Ni Y; Zhuge F; Chen G; Li H; Pan T; Yamashita T; Mukaida N; Kaneko S; Ota T; Nagata N
    Metabolism; 2021 Dec; 125():154914. PubMed ID: 34656648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL Is Involved in Runx2-Triggered Hepatic Infiltration of Macrophages in Mice with NAFLD Induced by a High-Fat Diet.
    Zhong L; Yuan J; Huang L; Li S; Deng L
    Biomed Res Int; 2020; 2020():6953421. PubMed ID: 32596356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.
    Rowles JL; Han A; Miller RJ; Kelly JR; Applegate CC; Wallig MA; O'Brien WD; Erdman JW
    Nutr Res; 2019 Mar; 63():95-105. PubMed ID: 30824402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding.
    Horakova O; Sistilli G; Kalendova V; Bardova K; Mitrovic M; Cajka T; Irodenko I; Janovska P; Lackner K; Kopecky J; Rossmeisl M
    Front Endocrinol (Lausanne); 2023; 14():1205703. PubMed ID: 37501785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet.
    Motiño O; Li S; Lambertucci F; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Chen H; Maiuri MC; Kroemer G; Martins I
    Methods Mol Biol; 2024; 2769():67-75. PubMed ID: 38315389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
    Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice.
    Jurado-Ruiz E; Varela LM; Luque A; Berná G; Cahuana G; Martinez-Force E; Gallego-Durán R; Soria B; de Roos B; Romero Gómez M; Martín F
    Mol Nutr Food Res; 2017 Mar; 61(3):. PubMed ID: 27749006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.